GRCE short interest
Grace Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,721,067 |
|---|---|
| Change vs prior report | -44,135 (-2.5%) |
| Change over six months | +4.1% |
| Days to cover | 19.03 (sector: 3.78) |
| Average daily volume | 90,442 |
| Rank in Healthcare | #17 of 922 by days to cover |
GRCE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,721,067 | -2.5% | 19.03 | 90,442 |
| 2026-09-15 | 1,765,202 | +11.3% | 8.56 | 206,110 |
| 2026-08-31 | 1,586,005 | -2.3% | 18.28 | 86,742 |
| 2026-08-14 | 1,623,570 | +2.1% | 7.92 | 205,010 |
| 2026-07-31 | 1,589,555 | -2.6% | 5.67 | 280,528 |
| 2026-07-15 | 1,631,403 | -4.3% | 9.16 | 178,144 |
| 2026-06-30 | 1,705,143 | -10.4% | 5.06 | 336,901 |
| 2026-06-15 | 1,902,823 | -5.6% | 6.95 | 273,941 |
| 2026-05-29 | 2,015,007 | -4.0% | 6.71 | 300,478 |
| 2026-05-15 | 2,098,572 | -4.6% | 4.40 | 477,206 |
| 2026-04-30 | 2,199,232 | +12.9% | 1.42 | 1,548,016 |
| 2026-04-15 | 1,948,693 | +17.9% | 1.53 | 1,275,282 |
| 2026-03-31 | 1,652,768 | +5.6% | 3.27 | 504,860 |
| 2026-03-13 | 1,565,407 | +300.8% | 3.33 | 469,691 |
| 2026-02-27 | 390,568 | +496.7% | 2.16 | 180,882 |
| 2026-02-13 | 65,459 | +70.1% | 1.20 | 54,653 |
| 2026-01-30 | 38,490 | -10.1% | 1.00 | 92,907 |
| 2026-01-15 | 42,809 | +34.5% | 1.00 | 153,748 |
| 2025-12-31 | 31,816 | +31.0% | 1.00 | 68,338 |
| 2025-12-15 | 24,289 | +37.0% | 1.00 | 61,412 |
| 2025-11-28 | 17,729 | -33.8% | 1.00 | 66,536 |
| 2025-11-14 | 26,759 | +20.6% | 1.00 | 46,188 |
| 2025-10-31 | 22,196 | -4.5% | 1.00 | 61,180 |
| 2025-10-15 | 23,235 | -93.4% | 1.00 | 83,703 |
| 2025-09-30 | 352,260 | +68.1% | 5.36 | 65,743 |
import finzdata as yf
yf.Ticker("GRCE").short_interest # every report since 2017
yf.Client().short_interest(["GRCE"], start="2018-01-01")Healthcare short interest · GRCE price history · Who owns GRCE · All short interest